Robert Love

Robert Love is an experienced professional in business development and commercialization, currently serving as the Business Development & Commercialisation Manager for Therapeutics at UNSW since January 2024. Previously, Robert held several leadership roles, including Business Development Lead at both the Australian Stroke and Heart Research Accelerator and The George Institute for Global Health, as well as at the Victor Chang Cardiac Research Institute. Robert's entrepreneurial experience includes serving as CEO and Commercialisation Lead at Pryzm Health, where the focus was on leveraging artificial intelligence and big health data to enhance patient diagnostics. Other notable positions include Head of Commercial Integration at Actelion, Head of Precision Health Applications at the Garvan Institute of Medical Research, and Vice President of Strategy & Marketing at Mylan. Robert holds an MBA from Macquarie Business School and a B.Sc in Biochemistry and Finance from UNSW.